Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oxaliplatin Regimen”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00513266
What this trial is testing

Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery

Who this might be right for
Colorectal CancerMetastatic Cancer
Centre Hospitalier Universitaire Vaudois 35
Not applicableUnknownNCT04886193
What this trial is testing

FLOT Combined With PD-1 in the First-line Treatment of Patients With Advanced Gastric Cancer and Peritoneal Metastasis

Who this might be right for
ChemotherapyGastric Cancer
Guangdong Provincial Hospital of Traditional Chinese Medicine 20
Testing effectiveness (Phase 2)Study completedNCT00399750
What this trial is testing

TREE-2: Three Regimens of Eloxatin in Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Sanofi 373
Testing effectiveness (Phase 2)Study completedNCT00066274
What this trial is testing

Comparison of Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
UNICANCER
Testing effectiveness (Phase 2)UnknownNCT01843829
What this trial is testing

A Feasibility Study of Chemo-radiotherapy to Treat Operable Oesophageal Cancer

Who this might be right for
Oesophageal Cancer
Lisette Nixon 85
Testing effectiveness (Phase 2)Ended earlyNCT01479465
What this trial is testing

Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma

Who this might be right for
Colorectal Cancer
Gilead Sciences 266
Testing effectiveness (Phase 2)UnknownNCT01670370
What this trial is testing

Trial of R-GemOx Regimen in Previously Untreated Elderly Patients With DLBCL.

Who this might be right for
Diffuse Large B-cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University 60
Testing effectiveness (Phase 2)Looking for participantsNCT06907342
What this trial is testing

Testing a Functional Precision Medicine Approach to Select Chemotherapy for Metastatic Colorectal Cancer (COSENSE-1)

Who this might be right for
Tumor, ColorectalOrganoidsTumoroid+3 more
St. Olavs Hospital 148
Testing effectiveness (Phase 2)Ended earlyNCT00755118
What this trial is testing

Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic Crc

Who this might be right for
Colorectal Cancer
University Hospital of Crete 24
Testing effectiveness (Phase 2)Study completedNCT00055822
What this trial is testing

Combination Chemotherapy and Oblimersen in Treating Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
The University of Texas Health Science Center at San Antonio 16
Testing effectiveness (Phase 2)Study completedNCT00615056
What this trial is testing

A Study Combining FOLFOX or FOLFIRI With AG-013736 or Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer After Failure Of One First Line Regimen

Who this might be right for
Colorectal Neoplasms
Pfizer 171
Testing effectiveness (Phase 2)UnknownNCT01963702
What this trial is testing

A Phase II Trial of Exploring the Predictive Factors of TX and XELOX Regimen in the First Line Treatment of MGC

Who this might be right for
Gastric Cancer
Fudan University 120
Testing effectiveness (Phase 2)Study completedNCT01882868
What this trial is testing

Aflibercept in Combination With FOLFIRI in Patients With Second-Line Metastatic Colorectal Cancer in Japan

Who this might be right for
Colorectal Cancer Metastatic
Sanofi 62
Testing effectiveness (Phase 2)UnknownNCT03271255
What this trial is testing

Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C)

Who this might be right for
Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal Neoplasms+1 more
Shenzhen People's Hospital 80
Testing effectiveness (Phase 2)Study completedNCT00016198
What this trial is testing

Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Prologue Research International
Testing effectiveness (Phase 2)Study completedNCT00291785
What this trial is testing

Phase I/II CT 2106 and 5-FU/FA in Colorectal Cancer

Who this might be right for
Colorectal Cancer
CTI BioPharma 48
Early research (Phase 1)Study completedNCT03162510
What this trial is testing

Biweekly SOLAR, as First-line C/T in Pts With Gastric, Pancreatic and Biliary Cancers

Who this might be right for
Gastric Cancer in SituPancreatic CancersBiliary Cancers
National Health Research Institutes, Taiwan 18
Large-scale testing (Phase 3)Ended earlyNCT00470340
What this trial is testing

Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic Patients

Who this might be right for
Liver NeoplasmsLiver CirrhosisCarcinoma, Hepatocellular+2 more
Assistance Publique - Hôpitaux de Paris 263
Testing effectiveness (Phase 2)UnknownNCT02896803
What this trial is testing

Fluorouracil and Oxaliplatin as First-line for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Instituto do Cancer do Estado de São Paulo 37
Testing effectiveness (Phase 2)Ended earlyNCT03488251
What this trial is testing

PK,PD,Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Gemcitabine and Oxaliplatin for the Treatment of Patients With Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's Lymphoma

Who this might be right for
Non-hodgkin Lymphoma,B CellRefractory Diffuse Large B-Cell LymphomaRelapsed Diffuse Large B-Cell Lymphoma
Molecular Templates, Inc. 8
Next Page